Kadence Bio
1 known investors
Find your way into Kadence Bio
Kadence Bio is a clinical-stage life sciences company developing therapeutics for conditions in sexual and mental health. Its lead asset, KH-001, is being developed as an FDA-approved treatment for premature ejaculation, alongside a pipeline of compounds targeting mood disorders.
Investors · 1
Frequently asked questions
- What does Kadence Bio do?
- Kadence Bio is a clinical-stage life sciences company developing therapeutics for conditions in sexual and mental health. Its lead asset, KH-001, is being developed as an FDA-approved treatment for premature ejaculation, alongside a pipeline of compounds targeting mood disorders.
- Who are Kadence Bio's investors?
- Kadence Bio's investors include Palo Santo VC.
